Swiss - Delayed Quote CHF
Novartis AG (NOVN.SW)
89.18
-0.92
(-1.02%)
At close: 5:18:31 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
18,999,000
17,619,000
14,458,000
14,236,000
15,071,000
Investing Cash Flow
-6,284,000
-7,513,000
5,596,000
1,468,000
4,208,000
Financing Cash Flow
-15,126,000
-11,742,000
-14,278,000
-20,562,000
-16,264,000
End Cash Position
7,058,000
11,459,000
13,393,000
7,517,000
12,407,000
Capital Expenditure
-4,152,000
-3,814,000
-2,753,000
-2,239,000
-2,556,000
Issuance of Debt
6,437,000
7,101,000
546,000
252,000
16,000
Repayment of Debt
-3,723,000
-2,711,000
-2,481,000
-2,837,000
-5,987,000
Repurchase of Capital Stock
-9,948,000
-8,331,000
-8,719,000
-10,652,000
-3,057,000
Free Cash Flow
14,847,000
13,805,000
11,705,000
11,997,000
12,515,000
12/31/2021 - 4/3/1995
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ROG.SW Roche Holding AG
254.50
-1.74%
SAN.PA Sanofi
88.57
-1.27%
RO.SW Roche Holding AG
268.60
-1.76%
AZN.L AstraZeneca PLC
10,014.00
-1.63%
NOV.DE Novo Nordisk A/S
57.78
-1.32%
BAYN.DE Bayer Aktiengesellschaft
22.20
-10.29%
GSK.L GSK plc
1,360.00
+0.15%
SNY Sanofi
49.74
-0.45%
PFE.DE Pfizer Inc.
19.80
-3.08%
SNW.F Sanofi
88.59
-1.68%